BIT514 Test, Bioinnovations and biobusiness, Test 1 (3 ov.)

Answer 3 out of 4 questions.

  1. Aspects in estiomation of commercialization of an invention. 4 points
  2. Depositing of "micro-organisms" and their usage regulations and patenting of. 4 points
  3. Is the following invention patentable according to present accepted regulations and/or history of law cases? The invention to be patented is bolded. Present clear arguments in the case. 4 points

    Animal test based on Oncoviruses: In a Swiss hospital, a new rabbit eye test has been developed. This technique is more painful (first class test) than the earlier test. This test utilizes new oncovirus infection. Technique is for studying pathogenesis of viral eye infections and for finding suitable therapeutic substances for these diseases. By test animal trials it is more confidential and rapid to acquire clinical phase 1 results and there will be less biohazard wastes than in the older method where it is more difficult to diminish viruses.


  4. Clarify shortly, but concisely the next terms concerning with bioptenting. 4 points

    5. a. PC
    b. First to file principle
    c. HUL
    d. Priority date
    e. WPI
    f. Statement period
    g. Enabling disclosure
    h. Cancelling of a patent
    i. Act on employee inventions
    j. Kokoku
    k. Kokai
    l. Specifications